prednisone has been researched along with Epithelial Neoplasms in 3 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flores-Terry, MA | 1 |
| Prado, MD | 1 |
| Romero-Aguilera, G | 1 |
| Garcia-Arpa, M | 1 |
| Villasanti-Rivas, N | 1 |
| Franco-Munoz, M | 1 |
| Aisner, SC | 1 |
| Dahlberg, S | 1 |
| Hameed, MR | 1 |
| Ettinger, DS | 1 |
| Schiller, JH | 1 |
| Johnson, DH | 1 |
| Aisner, J | 1 |
| Loehrer, PJ | 1 |
| Li, MC | 1 |
| Hsu, KP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study of Octreotide Treatment of Advanced, Recurrent Thymoma[NCT00003283] | Phase 2 | 38 participants (Anticipated) | Interventional | 1998-10-13 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisone and Epithelial Neoplasms
| Article | Year |
|---|---|
Combined drug therapy for ovarian carcinoma.
Topics: Antineoplastic Agents; Carcinoma; Cell Division; Cobalt Isotopes; Cytarabine; DNA, Neoplasm; Drug Sy | 1970 |
2 other studies available for prednisone and Epithelial Neoplasms
| Article | Year |
|---|---|
Neoplasia de celulas dendriticasblastica plasmocitoide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Back; Cyclophosphamide; Dendritic Cells; Disea | 2018 |
Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Onc
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Disease-Free Survival; ErbB Receptors; Female; Humans; | 2010 |